Cohero Health
said today that it raised more than $13.3 million, according to regulatory filings, in equity and Series A preferred stock. The company sold nearly all of its total offering amount of $13.6 million before closing the round. Over 50 investors have contributed to the offering, which had its 1st sale in October last year.
The company said it plans to use part of the funds for general working capital purposes, including the payment of salaries.
Get the full story at our sister site, Drug Delivery Business News.
The post Cohero raises $13.3m for connected inhaler tech appeared first on MassDevice.